Clinical Trial

Minimum Power and Frequency of Repeated Low-level Red-light to Effectively Control Myopia Progression

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 4, 2024 (before its estimated April 9, 2025 completion). Its status may not reflect the trial's current state.
Summary
To explore the minimum power and frequency of Repeated Low-level Red-light (RLRL) to control myopia progression in low-myopic children aged 8-10 years, and the rebound effect of low-myopic children after discontinuation of RLRL with different combinations of power and frequency.
Trial Details
NCT Number NCT06717048
Lead Sponsor Shanghai Eye Disease Prevention and Treatment Center
Conditions Myopia, Refractive Error - Myopia, Choroidal Thickness, Retina
Enrollment 108 participants
Start Date 2024-12-09
Primary Completion 2025-04-09 (estimated)
Study Completion 2025-06-09 (estimated)
Updated on ClinicalTrials.gov 2024-12-04